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While it is clear that Kaposi’s sarcoma-associated her-
pesvirus (KSHV or HHV-8) is the causative agent of a
number of malignancies including multicentric Castle-
man’s disease, primary effusion lymphoma, and Kaposi’s
sarcoma (KS), the molecular mechanisms of tumor
induction by this virus are still unclear. In part, KS
lesion presentation is thought to be driven primarily
through paracrine mechanisms and is mainly observed
in immunocompromised patients. Monocyte subsets,
including dendritic cells and macrophages, are crucial to
immune system functionality and are also skewed in KS
patients. The goals of this study were to investigate a
potential role for the E3 ubiquitin ligase K5 of KSHV,
which plays a role in viral immune evasion, in altering
monocyte functionality, thereby contributing to KSHV-
driven tumorigenesis.
A series of wild-type (WT) and mutant K5-expressing
stable cell lines were generated in THP-1 monocytic cell
line and examined. Surprisingly, these cells demon-
strated a serum-dependent increased growth rate and a
propensity to acidify the growth medium as compared
to vector-THP-1 cells. Biochemical examination indi-
cated that K5 induced aerobic glycolysis and other hall-
marks of the “Warburg Effect,” including increased
lactate production and glucose uptake. Observed
increases in Akt and total cellular tyrosine phosphoryla-
tion, combined with the serum-dependence, suggested a
role for receptor tyrosine kinases (RTKs). A human-
RTK array demonstrated increased activation of the Flt-
3, Axl, PDGFR-ß, and Flt-4 receptors in K5-expressing
versus vector cell lines. Subsequent testing demonstrated
increased sensitivity of K5-expressing THP-1 cells to
growth arrest and apoptosis by sunitinib and increased
ligand-dependent signaling. Dynamin inhibitor studies
showed that K5 can target these RTKs from the surface
to increase intracellular signaling. Additional molecular
details will be presented.
Overall, our studies demonstrate that the KSHV K5
protein is acting as a novel oncogene – the first viral
protein of its kind – to drive monocyte subset expansion
and alter cellular metabolism, contributing to a pro-
tumorigenic microenvironment. Intriguingly, the meta-
bolic changes observed are caused by a single KSHV
protein and thus serve as a useful model to study differ-
ent aspects of KS pathology and its overall regulation of
cellular metabolism. These studies also provide addi-
tional rationale for the currently ongoing clinical trials
of sunitinib, Gleevec, and rapamycin for the treatment
of KSHV-driven neoplasias. Finally, the ability of this
viral E3 ubiquitin ligase to drive metabolic changes pro-
vides the tantalizing suggestion that a cellular ligase may
be acting in a similar, either physiologic or oncogenic,
manner.
Acknowledgements
This article has been published as part of Infectious Agents and Cancer
Volume 5 Supplement 1, 2010: Proceedings of the 12th International
Conference on Malignancies in AIDS and Other Acquired*Correspondence: robert.means@yale.edu
Department of Pathology, Yale University School of Medicine, New Haven,
CT, USA
Full list of author information is available at the end of the article
Karki et al. Infectious Agents and Cancer 2010, 5(Suppl 1):A79
http://www.infectagentscancer.com/content/5/S1/A79
© 2010 Means et al; licensee BioMed Central Ltd.
Immunodeficiencies (ICMAOI). The full contents of the supplement are
available online at http://www.biomedcentral.com/1750-9378/5?issue=S1.
Published: 11 October 2010
doi:10.1186/1750-9378-5-S1-A79
Cite this article as: Karki et al.: The Kaposi’s sarcoma-associated
herpesvirus E3 ubiquitin ligase K5 acts as a novel oncogene, altering
cellular metabolism and signaling: implications for tumorigenesis.
Infectious Agents and Cancer 2010 5(Suppl 1):A79.
Submit your next manuscript to BioMed Central
and take full advantage of: 
• Convenient online submission
• Thorough peer review
• No space constraints or color figure charges
• Immediate publication on acceptance
• Inclusion in PubMed, CAS, Scopus and Google Scholar
• Research which is freely available for redistribution
Submit your manuscript at 
www.biomedcentral.com/submit
Karki et al. Infectious Agents and Cancer 2010, 5(Suppl 1):A79
http://www.infectagentscancer.com/content/5/S1/A79
Page 2 of 2
